Статии с изисквания за обществен достъп - Yaying DuНаучете повече
Не е налице никъде: 4
CAR-T cells targeting TSHR demonstrate safety and potent preclinical activity against differentiated thyroid cancer
H Li, X Zhou, G Wang, D Hua, S Li, T Xu, M Dong, X Cui, X Yang, Y Wu, ...
The Journal of Clinical Endocrinology & Metabolism 107 (4), 1110-1126, 2022
Изисквания: National Natural Science Foundation of China
TMEM158 may serve as a diagnostic biomarker for anaplastic thyroid carcinoma: an integrated bioinformatic analysis
H Li, Y Du, T Xu, R Zhang, G Wang, Z Lv, X Li
Current medical science 40, 1137-1147, 2020
Изисквания: US National Institutes of Health
A set of markers related to viral infection has a sex-sensitive Prognostic Value in Papillary thyroid carcinoma
D Wan, X Yang, G Li, Y Du, J Cao, Y Gao, Z Shu, Y Zhou, X Wei, R Guo, ...
The Journal of Clinical Endocrinology & Metabolism 106 (5), e2334-e2346, 2021
Изисквания: National Natural Science Foundation of China
Regulation of antitumor miR-205 targets oncogenes: Direct regulation of lymphoid specific helicase and its clinical significance
X Cui, X Yang, G Wang, H Li, S Li, T Xu, Y Wu, Z Zhang, X Li, Y Du, ...
Life Sciences 309, 120993, 2022
Изисквания: National Natural Science Foundation of China
Налице някъде: 16
Systematic immunotherapy target discovery using genome-scale in vivo CRISPR screens in CD8 T cells
MB Dong, G Wang, RD Chow, L Ye, L Zhu, X Dai, JJ Park, HR Kim, ...
Cell 178 (5), 1189-1204. e23, 2019
Изисквания: US Department of Defense, US National Institutes of Health, V Foundation, USA
In vivo CRISPR screening in CD8 T cells with AAV–Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma
L Ye, JJ Park, MB Dong, Q Yang, RD Chow, L Peng, Y Du, J Guo, X Dai, ...
Nature biotechnology 37 (11), 1302-1313, 2019
Изисквания: US Department of Defense, US National Institutes of Health, V Foundation, USA
One-step generation of modular CAR-T cells with AAV–Cpf1
X Dai, JJ Park, Y Du, HR Kim, G Wang, Y Errami, S Chen
Nature Methods 16 (3), 247-254, 2019
Изисквания: US Department of Defense, US National Institutes of Health, V Foundation, USA
A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy
L Ye, JJ Park, L Peng, Q Yang, RD Chow, MB Dong, SZ Lam, J Guo, ...
Cell metabolism 34 (4), 595-614. e14, 2022
Изисквания: US Department of Defense, US National Institutes of Health, V Foundation …
CRISPR-GEMM pooled mutagenic screening identifies KMT2D as a major modulator of immune checkpoint blockade
G Wang, RD Chow, L Zhu, Z Bai, L Ye, F Zhang, PA Renauer, MB Dong, ...
Cancer discovery 10 (12), 1912-1933, 2020
Изисквания: US Department of Defense, US National Institutes of Health, V Foundation, USA
SIX1 activates STAT3 signaling to promote the proliferation of thyroid carcinoma via EYA1
D Kong, A Li, Y Liu, Q Cui, K Wang, D Zhang, J Tang, Y Du, Z Liu, G Wu, ...
Frontiers in oncology 9, 1450, 2019
Изисквания: National Natural Science Foundation of China
Massively parallel knock-in engineering of human T cells
X Dai, JJ Park, Y Du, Z Na, SZ Lam, RD Chow, PA Renauer, J Gu, S Xin, ...
Nature biotechnology 41 (9), 1239-1255, 2023
Изисквания: US Department of Defense, US National Institutes of Health
The association between Foxp3 polymorphisms and risk of graves' disease: A systematic review and meta-analysis of observational studies
H Li, X Li, Y Du, Z Yang, Z Lv
Frontiers in endocrinology 11, 392, 2020
Изисквания: National Natural Science Foundation of China
Current landscape of personalized clinical treatments for triple-negative breast cancer
J Zhang, Y Xia, X Zhou, H Yu, Y Tan, Y Du, Q Zhang, Y Wu
Frontiers in Pharmacology 13, 977660, 2022
Изисквания: National Natural Science Foundation of China
Cyclin-Dependent Kinase Inhibitors Function as Potential Immune Regulators via Inducing Pyroptosis in Triple Negative Breast Cancer
T Xu, Z Wang, J Liu, G Wang, D Zhou, Y Du, X Li, Y Xia, Q Gao
Frontiers in Oncology 12, 820696, 2022
Изисквания: National Natural Science Foundation of China
MiR-205-5p/GGCT attenuates growth and metastasis of papillary thyroid cancer by regulating CD44
HN Li, HM Zhang, XR Li, J Wang, T Xu, SY Li, ML Dong, G Wang, XQ Cui, ...
Endocrinology 163 (4), bqac022, 2022
Изисквания: National Natural Science Foundation of China
Targeting the inward rectifier potassium channel 5.1 in thyroid cancer: artificial intelligence-facilitated molecular docking for drug discovery
X Yang, Y Wu, S Xu, H Li, C Peng, X Cui, DK Dhoomun, G Wang, T Xu, ...
BMC Endocrine Disorders 23 (1), 113, 2023
Изисквания: National Natural Science Foundation of China
CAR-T cells targeting thyroid-stimulating hormone receptor (TSHR) demonstrate safety and potent preclinical activity against differentiated thyroid cancer
H Li, X Zhou, G Wang, D Hua, S Li, T Xu, M Dong, X Cui, X Yang, Y Wu, ...
medRxiv, 2021.05. 15.21256466, 2021
Изисквания: National Natural Science Foundation of China
Case report: Long-term survival with anlotinib in a metastatic parathyroid carcinoma patient harboring EGFR-sensitizing mutation
Y Ying, H Li, W Xia, T Cheng, H Li, Q Fu, T Ai, Y Yang, N Zhang, X Li, ...
Изисквания: National Natural Science Foundation of China
A miR-205-5p/GGCT/CD44 axis controls the progression of papillary thyroid cancer
H Li, H Zhang, X Li, J Wang, T Xu, S Li, M Dong, G Wang, X Cui, X Yang, ...
Изисквания: National Natural Science Foundation of China
Rapid modular CAR-T generation with CRISPR/Cpf1 and AAV systems
S Chen, X Dai, J Park, Y Du
Изисквания: US Department of Defense, US National Institutes of Health, V Foundation, USA
Информацията за публикацията и осигуреното финансиране се определя автоматично от компютърна програма